FIELD: medicine.
SUBSTANCE: present invention relates to medicine, particularly to a pharmaceutical composition comprising atropine or a salt thereof; aconitine and mercuric cyanide for use in a method for treating a viral infection, caused by the herpes virus, respiratory syncytial virus (RSV), rhinoviruses and/or enteroviruses. Compositions possess a broad therapeutic spectrum, better tolerability and fewer drug interactions and are not at risk of developing resistance.
EFFECT: antiviral effective pharmaceutical composition is proposed.
7 cl, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL APPLICATION FOR A-SYMPATHOMIMETICS WHICH HAVE 2-IMIDASOLIN STRUCTURE | 2005 |
|
RU2397764C2 |
| ANTIVIRAL COMPOSITION | 2020 |
|
RU2740660C1 |
| METHOD FOR PRODUCING PROPHYLACTIC ANTIVIRAL COMPOSITION BASED ON EPIGALLOCATECHIN-3-GALLATE (EGCG) | 2021 |
|
RU2771898C1 |
| ANTIVIRAL COMPOSITION | 2020 |
|
RU2740657C1 |
| COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | 2009 |
|
RU2505306C2 |
| RNAI-MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND APPLICATION THEREOF | 2005 |
|
RU2409666C2 |
| IRNA AGENT FOR REDUCING LEVELS OF VIRAL PROTEIN, IRNA OR RESPIRATORY SYNCYTIAL VIRUS TITRE IN RESPIRATORY CELL | 2005 |
|
RU2494745C2 |
| ANTIVIRAL COMPOSITION | 2012 |
|
RU2584245C2 |
| ANTIVIRAL AGENT BASED ON HUMIC ACIDS | 2018 |
|
RU2678986C1 |
| USING POLYCARBOXYLIC FULLERENE DERIATIVE AS MICROBIOCIDAL ANTIVIRAL AGENT | 2012 |
|
RU2533232C2 |
